ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW - Direct Plan

Other Plans and Options
  • (-0.19%)Nav, as on 09-12-2025

  • Previous Nav

  • Net Change on 09-12-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option -0.61 -0.31 2.62 27.95 19.07 21.70
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 2.62 27.95 19.07 1.02 6,459.82
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 -0.15 23.61 17.44 0.61 1,338.85
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 -0.15 23.61 17.44 0.61 1,338.85
UTI Healthcare Fund - Direct Plan - IDCW Jan 01, 2013 -1.38 24.79 16.70 1.29 1,126.13

Fund Holdings as on 30-November-2025

  • Sun Pharmaceutical Industries Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Cipla Ltd.

  • Divi's Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • Lupin Ltd.

  • Mankind Pharma Ltd.

  • Alkem Laboratories Ltd.

  • Syngene International Ltd.

  • Cohance Lifesciences Ltd

  • Zydus Lifesciences Ltd.

  • TREPS

  • Biocon Ltd.

  • Thyrocare Technologies Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Medi Assist Healthcare Services Ltd

  • J.B.Chemicals & Pharmaceuticals Ltd.

  • Gland Pharma Ltd.

  • Blue Jet Healthcare Ltd.

  • Pfizer Ltd.

  • Medplus Health Services Ltd

  • Metropolis Healthcare Ltd.

  • Fine Organic Industries Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Star Health & Allied Insurance

  • Windlas Biotech Ltd.

  • Anthem Biosciences Ltd

  • Shilpa Medicare Ltd.

  • Aarti Drugs Ltd.

  • Hikal Ltd.

  • Sanofi Consumer Healthcare India Ltd

  • Senores Pharmaceuticals Ltd

  • Astrazeneca Pharma India Ltd.

  • FDC Ltd.

  • Rubicon Research Ltd

  • Laxmi Dental Ltd.

  • Procter & Gamble Health Ltd.

  • Sun Pharma Advanced Research Co. Ltd

  • Akums Drugs and Pharmaceuticals Ltd.

  • Cash Margin - Derivatives

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Business Support

  • Hospital & Healthcare Services

  • Miscellaneous

  • Retailing

  • Chemicals

  • Insurance

  • Medical Equipment/Supplies/Accessories

View More

Most Recent Dividend

  • 08/08/2025

  • 07/08/2024

  • 16/08/2023

  • 12/08/2022

  • 13/08/2021

  • 06/08/2020

  • Cash

  • Equity

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹6,459.82 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended down ₹-0.05(-0.19%)yesterday to ₹25.84.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100